Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 23748915)

1.

Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas.

Coutinho-Camillo CM, Lourenço SV, Nonogaki S, Vartanian JG, Nagai MA, Kowalski LP, Soares FA.

Virchows Arch. 2013 Jul;463(1):31-9. doi: 10.1007/s00428-013-1438-9. Epub 2013 Jun 9.

PMID:
23748915
2.

Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC.

BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.

3.

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.

4.

Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.

Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA.

Breast Cancer Res Treat. 2007 Nov;106(1):49-56. Epub 2007 Jan 9.

PMID:
17211533
5.

Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.

Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Warnakulasuriya S, Forteza J, Fraga M.

J Oral Pathol Med. 2012 Aug;41(7):559-67. doi: 10.1111/j.1600-0714.2012.01142.x. Epub 2012 Mar 14.

PMID:
22417132
6.

Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC.

Eur J Cancer. 2012 Sep;48(14):2166-74. doi: 10.1016/j.ejca.2012.04.010. Epub 2012 Aug 12.

PMID:
22892062
7.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
8.

HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.

Bitu CC, Destro MF, Carrera M, da Silva SD, Graner E, Kowalski LP, Soares FA, Coletta RD.

BMC Cancer. 2012 Apr 12;12:146. doi: 10.1186/1471-2407-12-146.

9.

HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.

Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Buerger H.

BMC Cancer. 2005 Jul 21;5:84.

10.

Caspase expression in oral squamous cell carcinoma.

Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA.

Head Neck. 2011 Aug;33(8):1191-8. doi: 10.1002/hed.21602. Epub 2010 Nov 12.

PMID:
21755562
11.

P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.

Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggiò MA, Rubini C, Procaccini M, Dolci M, Bufo P, De Rosa G, Piattelli A.

Histol Histopathol. 2004 Oct;19(4):1089-99.

PMID:
15375751
12.

TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.

Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K.

Mod Pathol. 2008 Feb;21(2):186-91. Epub 2007 Dec 14.

13.

Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.

Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Yamamoto E.

J Oral Pathol Med. 2008 Jul;37(6):364-71. doi: 10.1111/j.1600-0714.2008.00642.x. Epub 2008 Apr 10.

PMID:
18410312
14.

Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.

Leung KW, Tsai CH, Hsiao M, Tseng CJ, Ger LP, Lee KH, Lu PJ.

Oncol Rep. 2009 Apr;21(4):1097-104.

PMID:
19288014
15.

HIF-1alpha is a prognostic marker in oral squamous cell carcinomas.

Eckert AW, Schutze A, Lautner MH, Taubert H, Schubert J, Bilkenroth U.

Int J Biol Markers. 2010 Apr-Jun;25(2):87-92.

PMID:
20544685
16.

Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma.

Lin YT, Chuang HC, Chen CH, Armas GL, Chen HK, Fang FM, Huang CC, Chien CY.

BMC Cancer. 2012 May 28;12:194. doi: 10.1186/1471-2407-12-194.

17.

Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray.

Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA.

Hum Pathol. 2010 Aug;41(8):1079-86. doi: 10.1016/j.humpath.2009.12.010. Epub 2010 Mar 24.

PMID:
20338617
18.

High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients.

Chen CJ, Sung WW, Su TC, Chen MK, Wu PR, Yeh KT, Ko JL, Lee H.

Clin Chim Acta. 2013 Jan 16;415:25-30. doi: 10.1016/j.cca.2012.09.009. Epub 2012 Sep 12.

PMID:
22981868
19.

Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption.

Chen YW, Kao SY, Yang MH.

J Surg Oncol. 2012 Aug 1;106(2):149-54. doi: 10.1002/jso.23067. Epub 2012 Feb 21.

PMID:
22354873
20.

P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.

Lo Muzio L, Campisi G, Farina A, Rubini C, Pannone G, Serpico R, Laino G, De Lillo A, Carinci F.

BMC Cancer. 2005 Jun 21;5:63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk